Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FEC vs EC-Doc in Primary Breast Cancer
NCT00047099Phase 3Completed
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Aug 2001
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in breast cancer, sponsored by Ludwig Maximilian University of Munich. Started Aug 2001; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00047099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047099.